Tag Archives: Biotechnology Industry Organization

The 2014 Farm Bill Becomes Law at MSU

farm-bill-signing-group-shot-115x76

The Lansing State Journal recently published an noteworthy editorial titled Allen Julian and Peter Pellerito: MSU a good site to sign Farm Bill. Allen Julian is the chief business officer of MBI International and Peter Pellerito is a senior policy Consultant at the Biotechnology Industry Organization. Both provide readers excellent insight to why Michigan was a fitting choice for the final signing of the 2014 Farm Bill: When President Obama toured the MBI facility and Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Submits Comments to the EPA’s 2014 RVO Proposed Rule

Gas-Can-Spilling-Corn-115x76

The public comment period for the Environmental Protection Agency’s (EPA) 2014 proposal on the Renewable Volume Obligations (RVO) closed Tuesday January 28, 2014, with the agency receiving 16,575 comments.  On behalf of its members, BIO submitted over fifty pages of comments, stressing that the proposed changes to the RFS would be detrimental to the cellulosic and advanced biofuels industry. In a recent press release, Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section, stated Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Joins Partners for Healthy Dialogues

Jim Greenwood

The Biotechnology Industry Organization (BIO) recently joined the Partners for Healthy Dialogues effort. Dialogues+ had the opportunity to ask Jim Greenwood, President and CEO of BIO, about why BIO joined the effort, the importance of collaboration and preparing for the Physician Payments Sunshine Act. “BIO and our members support transparency in the life science industry and in the relationships between industry and physicians. We also strongly believe in the value of such relationships for the Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

New BIO Survey on Effective FDA – Sponsor Communication During Drug Development

BIO Logo Horizontal 4C copy

BIO is surveying members on their interactions with the FDA during the various stages of drug development prior to submitting an NDA/BLA. The survey can be accessed here. In an increasingly competitive and fiscally-constrained environment, it is more important than ever for all stakeholders to work together to promote effective R&D for innovative medicines. This initial survey is designed to assist in the implementation of the Prescription Drug User Fee Act (PDUFA V) program on Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

FDA: How can we improve it?

Stephen Sherwin MD

By Stephen Sherwin, Former Chairman of BIO As Congress and the President work together to hammer out a new, national economic roadmap, it is important to point out to those working in, and interested in, our industry that we too have recently assembled a roadmap – one designed to fully realize the promise our industry holds for people everywhere. Several weeks ago, at the 2011 BIO International Convention in Washington, DC, BIO unveiled its first ever 5 Read More >

Corporate  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,